Fonthal Regulatory Group | A Division of INTEDCO

FDA Regulatory Services

Fonthal Regulatory Group provides specialized regulatory consulting services for medical device manufacturers and international companies navigating U.S. FDA requirements.

A professional consultant reviewing FDA regulatory documents with a medical device prototype on the desk.
A professional consultant reviewing FDA regulatory documents with a medical device prototype on the desk.

Regulatory Services Offered

  • U.S. Agent Representation & FDA Liaison

  • 510(k) Premarket Notification Support

  • FDA Establishment Registration & Device Listing

  • Labeling & Packaging Compliance Review

  • Post-Market Surveillance Support

  • FDA Correspondence & Communication Management

  • Regulatory Gap Analysis

  • International Market Entry Consulting

  • De Novo Classification Request Support

  • PMA Pre-Market Approval Assistance

  • FDA Inspection Preparation & Response

Compliance Is Our Focus

Fonthal Regulatory Group applies a rigorous, detail-oriented approach to every client engagement — ensuring that every submission, registration, and compliance strategy meets the highest FDA standards.

Close-up of a medical device with regulatory documents and a pen on a desk.
Close-up of a medical device with regulatory documents and a pen on a desk.
Premarket Submission Strategy & Support

Fonthal Regulatory Group provides comprehensive 510(k) premarket notification support for medical device manufacturers seeking FDA clearance. From initial device classification and predicate identification to submission preparation and FDA correspondence management, the firm guides clients through every stage of the premarket review process with precision and strategic insight.

A professional consultant reviewing FDA submission paperwork with a client in a modern office.
A professional consultant reviewing FDA submission paperwork with a client in a modern office.
U.S. Agent & FDA Liaison Services

As a designated U.S. Agent, Fonthal Regulatory Group serves as the official point of contact between foreign medical device manufacturers and the U.S. Food and Drug Administration. The firm ensures timely and accurate communication with the FDA on behalf of international clients, fulfilling all U.S. Agent obligations as required under 21 CFR Part 807 and supporting ongoing compliance with U.S. regulatory requirements.

Contact

info@intedcousa.com

+1 949-201-7962

© 2025-2026. All rights reserved.